P
Paul Olivier
Researcher at Howard Hughes Medical Institute
Publications - 2
Citations - 1164
Paul Olivier is an academic researcher from Howard Hughes Medical Institute. The author has contributed to research in topics: Cyclin D & Cyclin-dependent kinase. The author has an hindex of 1, co-authored 1 publications receiving 1138 citations. Previous affiliations of Paul Olivier include Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
Mangeng Cheng,Paul Olivier,Paul Olivier,J. Alan Diehl,J. Alan Diehl,Matthew L. Fero,Matthew L. Fero,Martine F. Roussel,James M. Roberts,James M. Roberts,Charles J. Sherr,Charles J. Sherr +11 more
TL;DR: In the absence of both CKIs, the severe reduction in cyclin D‐dependent kinase activity was well tolerated and had no overt effects on the cell cycle.